At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Cancer
In Brief
A Phase 2 clinical trial evaluating Counseling, Methylphenidate Hydrochloride, and 5 other interventions for Hematopoietic and Lymphoid Cell Neoplasm and 2 related conditions. Active but no longer recruiting, targeting 68 participants across 1 site.
Detailed Summary
This randomized phase II trial studies how well cognitive behavioral therapy and multimodal therapy works in treating sleep disturbance in patients with cancer. Cognitive behavioral therapy may help reduce sleep disturbances, fatigue, and insomnia as well as improve the well-being and quality of life of patients with cancer when given together with methylphenidate hydrochloride, therapeutic melatonin, and light therapy.
Study Details
Timeline
Interventions
Undergo CBT
Given PO
Undergo light therapy
Given PO
Ancillary studies
Undergo sham light therapy
Given PO